Artificial intelligence (AI) is rapidly becoming an established arm in medical sciences and
clinical practice in numerous medical fields. Its implications have been rising and are being …

Sickle cell disease (SCD) is a genetic disease influenced by ethnicity and regional
differences in its clinical course. Recent advances in the management of SCD with newer …

Sickle cell disease (SCD) or homozygous sickle cell anemia is the most common inherited
disorder of erythrocytes, characterized by the presence of pathologic hemoglobin S (HbS). A …

It was clearly realized more than 50 years ago that iron deposition in the liver may be a
critical factor in the development and progression of liver disease. The recent clarification of …

Despite regular blood transfusion and iron chelation therapy, growth impairment and
pubertal delay are commonly seen in children and adolescents with transfusion-dependent …

Materials and Methods This case-control study included 253 SCD (153 SCD-transfused and
100 SCD non-transfused). We evaluated the transfusion practice (modalities, indications) …

Sickle cell disease (SCD) is an autosomal recessive genetic disorder that affects∼ 100,000
Americans and millions of people worldwide. Erythrocyte sickling, vaso-occlusion, sterile …

Background Deferoxamine (DFO) or Deferiprone (DFP) or Deferasirox (DFX) monotherapy
and DFO and DFP combination therapy (DFO+ DFP) were four commonly implemented now …

Sickle cell disease (SCD) is an inherited hemoglobinopathy with protean clinical
manifestations. The liver could be affected by various SCD-associated complications of an …

Objectives Pancreatic reserve could be preserved by early assessment of pancreatic iron
overload among transfusion-dependent sickle cell disease (SCD) patients. This study aimed …